These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9865123)

  • 1. [Diagnosis and treatment of ocular viral infections in AIDS patients].
    Guex-Crosier Y
    Rev Med Suisse Romande; 1998 Nov; 118(11):941-7. PubMed ID: 9865123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cystoid macular edema and cytomegalovirus retinitis in AIDS patients treated with antiretroviral triple therapy].
    Badelon I; Gohier P; Chaine G
    J Fr Ophtalmol; 1999 Dec; 22(10):1034-41. PubMed ID: 10617840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Examination of the posterior eye segment during HIV infection: what is new?].
    Guex-Crosier Y
    Klin Monbl Augenheilkd; 1999 May; 214(5):317-20. PubMed ID: 10420376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral leishmaniasis in HIV-infected patients with non-detectable HIV-1 viral load after highly active antiretroviral therapy.
    Jiménez-Expósito MJ; Alonso-Villaverde C; Sardà P; Masana L
    AIDS; 1999 Jan; 13(1):152-3. PubMed ID: 10207569
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretroviral therapy.
    De Luca A; Ammassari A; Cingolani A; Giancola ML; Antinori A
    AIDS; 1998 Oct; 12(14):1937-8. PubMed ID: 9792402
    [No Abstract]   [Full Text] [Related]  

  • 8. Resolution of disseminated molluscum contagiosum with Highly Active Anti-Retroviral Therapy (HAART) in patients with AIDS.
    Calista D; Boschini A; Landi G
    Eur J Dermatol; 1999; 9(3):211-3. PubMed ID: 10210787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kaposi sarcoma in HIV patients: Response to antiretroviral treatment and chemotherapy].
    Lasso M; Pérez J; Noriega L; Malebrán A; Espinoza S
    Rev Med Chil; 2003 May; 131(5):483-90. PubMed ID: 12879808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal of Mycobacterium avium complex suppressive therapy in HIV-1-infected patients on highly active antiretroviral therapy.
    Martínez E; Miró JM; González J; Mallolas J; Gatell JM
    AIDS; 1999 Jan; 13(1):147-8. PubMed ID: 10207565
    [No Abstract]   [Full Text] [Related]  

  • 11. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
    Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
    Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients.
    Revankar SG; Sanche SE; Dib OP; Caceres M; Patterson TF
    AIDS; 1998 Dec; 12(18):2511-3. PubMed ID: 9875598
    [No Abstract]   [Full Text] [Related]  

  • 14. State of the art: antiretroviral and prophylactic treatments in HIV/AIDS.
    Porche DJ
    Nurs Clin North Am; 1999 Mar; 34(1):95-112. PubMed ID: 9922281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Viral lesions of the eye in human immunodeficiency virus infection].
    Krasnov MM; Marchenko NR
    Vestn Oftalmol; 1998; 114(5):35-9. PubMed ID: 9865183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cessation of anti-CMV therapy in patients with CMV retinitis.
    Dunn JP
    Hopkins HIV Rep; 1998 Mar; 10(2):11. PubMed ID: 11365137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Kedhar SR; Jabs DA
    Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression.
    Václavíková J; Weber J; Machala L; Reinis M; Linka M; Brůcková M; Vandasová J; Stanková M; Konvalinka J
    Acta Virol; 2005; 49(1):29-36. PubMed ID: 15929396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up to management strategies for candidates for protease inhibitors and requiring treatment for Mycobacterium tuberculosis.
    Tseng A; Walmsley S
    Can Commun Dis Rep; 1998 Aug; 24(16):129-32. PubMed ID: 9727271
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.